drugset / Trial / NCT00796601
Maintenance of Efficacy.
RandomizedParallel-groupDouble-blindTreatment
Summary
The hypothesis of Study A6061054 is to demonstrate superiority of efficacy of esreboxetine at 3 and 6 months compared to placebo.
Timeline
- Start
- 2009-05-01
- Primary completion
- 2010-05-01
- Completion
- 2010-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [S,S]-Reboxetine | Unknown | 2 mg | — |
| Subject | [S,S]-Reboxetine | Unknown | 6 mg | — |
| Subject | [S,S]-Reboxetine | Unknown | 8 mg | — |
| Subject | [S,S]-Reboxetine | Unknown | 10 mg | — |